Yan, Ling
Li, Yanli
Fan, Fengmei
Gou, Mengzhuang
Xuan, Fangling
Feng, Wei
Chithanathan, Keerthana
Li, Wei
Huang, Junchao
Li, Hongna
Chen, Wenjin
Tian, Baopeng
Wang, Zhiren
Tan, Shuping
Zharkovsky, Alexander
Hong, L. Elliot
Tan, Yunlong
Tian, Li
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (81771452, 82171507)
Eesti Teadusagentuur (MOBTT77, PRG878)
NIH Blueprint for Neuroscience Research (R01MH112180)
Article History
Received: 28 February 2023
Accepted: 22 June 2023
First Online: 4 August 2023
Declarations
:
: The clinical part of the study was approved by the Institutional Ethical Committee of Beijing Huilongguan Hospital with license #2017-49. Written informed consent was obtained from each subject. The preclinical part of the study was approved by the Estonian National Board of Animal Experiments with license #171.
: All authors have consent for publication of the current work.
: LEH has received or plans to receive research funding or consulting fees on research projects from Mitsubishi, Your Energy Systems LLC, Neuralstem, Taisho, Heptares, Pfizer, Luye Pharma, IGC Pharma, Sound Pharma, Takeda, and Regeneron. None was involved in the design, analysis, or outcomes of the study. All other authors declare no competing commercial and financial interests.